Abattis Bioceuticals Corp.

(CSE:ATT) (OTC:ATTBF)

Company Description:

Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

Latest News & Stories on Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF)

Abattis to Launch New Cannabis Lab in Ontario

June 28, 2018

Abattis Bioceuticals Announces Release of New Line of Vaporizers

May 22, 2018

Abattis Adds Significant Strength to its Board and Leadership Team

May 15, 2018

Abattis to Begin Construction of 26,000 Square Foot Facility in B.C.

May 3, 2018

Abattis Signs LOI to Manufacture CBD-Infused Mineral Water

March 13, 2018

Abattis to Provide Kanabé a Full Suite of Downstream Cannabis Solutions

March 8, 2018

Abattis Rebrands as a Downstream Solutions Provider

March 6, 2018

Abattis Completes Gabriola Green Farms Acquisition

March 2, 2018

Abattis to Acquire 90% of ACMPR Applicant Gabriola Green Farms

February 27, 2018

Abattis Awarded Grant for R&D of Cannabinoid-rich Hemp Oil

February 12, 2018

Abattis to Acquire 49% Stake In CannaNUMUS Blockchain

February 1, 2018

Abattis Partners with Craft Brewer to Develop Hemp-Infused Beer

January 22, 2018

Abattis Announces LOI for Partnership with Alliance of Beverage Licensees

January 9, 2018

Abattis Announces Letter of Intent to Acquire Winston Resources

December 22, 2017

Northern Vine Labs Expands Dealer’s License with Health Canada

December 15, 2017

Abattis Confirms Breakthrough Extraction Technology Capabilities

December 12, 2017

Emerald Health Therapeutics to Acquire Control of Northern Vine from Abattis

October 26, 2017

5 Highlights From Abattis' Update On Northern Vine Labs

August 23, 2017

Abattis Bioceuticals Appoints Two New Board Members

June 7, 2017

30+ Marijuana Companies Included in CSE Composite Index

May 16, 2017

Northern Vine Lab Completes First Test Analysis

May 3, 2017

Abattis Bioceuticals Signs Cannabis Extraction Technology Distribution Agreement

April 26, 2017

Canada Licensed Dealers List

December 12, 2016

Abattis Bioceuticals Corp. Issues Shares and Warrants

November 21, 2016

Abattis Appoints Dr. Shuang Xie as Director, Provides Progress Report on China Initiatives

November 14, 2016

Experion Biotechnologies Prepares for Construction

October 17, 2016

Abattis Signs MOU With Global Damon Pharma of South Korea

October 5, 2016

Abattis' Northern Vine Labs Receives Controlled Substance License

October 3, 2016

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.